ページの先頭です
HOME > Past Issue List > Issue List > Abstract
言語を選択(Language)
日本語(Japanese)English

Abstract

Vol.65 No.4 July 2017

The role of infectious disease chemotherapy pharmacist and support for inpatient pharmacists: The field of urology

Satoshi Fujii1), Kaoru Yoshioka1), Yusuke Kunimoto1), Shogo Seiji1), Yoshiki Hiyama2), Satoshi Takahashi3), Naoya Masumori2) and Atsushi Miyamoto1)

1)Department of Hospital Pharmacy, Sapporo Medical University Hospital, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, Japan
2)Department of Urology, Sapporo Medical University School of Medicine
3)Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine

Abstract

In Japan, "For the Promotion of the Antimicrobial Stewardship (AS) Program" was published in 2016 by eight societies with regards to the appropriate usage of antibacterial agents, and it is indeed an important topic to promote. Presently, at Sapporo Medical University Hospital, the Infection Control Team is performing rounds for the appropriate use of antibacterial agents, but it could not follow-up infected patients in all clinical departments. Nowadays, when inpatient pharmacists are assigned to all hospital wards, to follow-up patients with infections in more clinical departments, the help of inpatient pharmacists is essential. It is important for infectious disease chemotherapy pharmacists to improve the skills of inpatient pharmacists and to provide support for infection treatment by offering consultations with inpatient pharmacists. Urinary tract infection is especially common among many clinical departments, and antibacterial agents that are effective against intestinal bacteria, such as gram-negative bacilli, are used for treatment. However, in recent years, there have been a large number of reports of extended spectrum β-lactamase-producing strains, quinolone-resistant Escherichia coli, and multi-drug resistant Pseudomonas aeruginosa, and in some cases, existing treatments with antibacterial agents were insufficient. A cause for such drug resistance may be the inappropriate use of antibacterial agents; thus, appropriate usage of antibacterial agents that takes such drug resistance into consideration is strongly needed and recommended. Infectious disease chemotherapy pharmacists need to evaluate the appropriate usage of antibacterial agents within the hospital, support inpatient pharmacists in treating infections, and appropriately use antibacterial agents throughout the infection treatment procedure.

Key word

infectious disease chemotherapy pharmacist, appropriate use, antimicrobial stewardship, urinary tract infection

Received

January 30, 2017

Accepted

March 8, 2017

Jpn. J. Chemother. 65 (4): 564-567, 2017